The MISSION of the MND Association is to fund research aimed at increasing treatment options and improving the clinical and healthcare practice for Amyotrophic Lateral Sclerosis (ALS) and related conditions. This effort supports not only people living with MND but also caregivers and families, focusing on research that informs and expands the NICE Guideline for Motor Neurone Disease through identifying knowledge gaps and generating a robust evidence base to strengthen the case for high-quality MND care funding.
The MND Association's Biomedical Project Grants aim to support specific research projects focused on ALS and related conditions. These projects should be designed to answer a singular question or a small group of related questions. Grants typically support projects of limited duration, with consideration for applications up to three years. Funding is intended for bona fide research institutions, with annual reviews and progress reports required. Non-London Institutes can receive up to £95,000 per annum (£285,000 in total), while London Institutes may receive up to £100,000 per annum (£300,000 in total), barring prior agreement with the MND Association.